Fumarate Esters as Angiogenesis Inhibitors: Key to Action in Psoriasis?
- 1 June 2011
- journal article
- editorial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 131 (6) , 1189-1191
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Dimethylfumarate Inhibits Angiogenesis In Vitro and In Vivo: A Possible Role for Its Antipsoriatic Effect?Journal of Investigative Dermatology, 2011
- Suppression of VEGFR2 Expression in Human Endothelial Cells by Dimethylfumarate Treatment: Evidence for Anti-Angiogenic ActionJournal of Investigative Dermatology, 2011
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2010
- HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal CarcinomaCancer Cell, 2008
- Cell-Permeating α-Ketoglutarate Derivatives Alleviate Pseudohypoxia in Succinate Dehydrogenase-Deficient CellsMolecular and Cellular Biology, 2007
- Targeted Inactivation of Fh1 Causes Proliferative Renal Cyst Development and Activation of the Hypoxia PathwayCancer Cell, 2007
- Hypoxia-inducible factor 1α stabilization by carbon monoxide results in cytoprotective preconditioningProceedings of the National Academy of Sciences, 2007
- Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle miceJournal of Clinical Investigation, 2006
- Germline Fumarate Hydratase Mutations in Families with Multiple Cutaneous and Uterine LeiomyomataJournal of Investigative Dermatology, 2003
- Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerNature Genetics, 2002